Kangstem Biotech

본문 바로가기

KOR | ENG

주메뉴

Company
- Company
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Company Overview
- Welcome Message
- Founder
- CEO
- Vision & Mission
- Location
Business
- Business
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Stem Cell Therapy
- FURESTEM-OA Kit Inj.
- FURESTEM-AD® Inj.
- FURESTEM-RA® Inj.
- Advanced Regenerative Medicine
- Organoid
- Skin Organoid
- Islet Organoid
- Stem Cell and CDMO Business
- JUVENTAS
- Stem Cell Culture Business
- CDMO
- Health&Beauty Business
R & D
- R & D
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Core Technology
- Exclusive Technology
- Umbilical Cord Blood Stem Cell
- High-Compact Technology Strategy
- Global R&D Center
- Stem Cell GMP Center
Investors
- Investors
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Notice
- PR
- Press Release
- PR Resource Center

Core Technology

Exclusive Technology

Kangstem Biotech strives to develop an innovative new drug for patients suffering from rare and incurable diseases.

Exclusive
Technology

Cord Blood-Derived Stem Cell
Isolation and Mass Culture
Technologies

Cord Blood-Derived Stem Cell Isolation Technology and Mass Medium Technology

As the cord blood has a very small amount of existed mesoderm stem cells different from adipose or marrow, it is necessary to have a culture technology to identify the stem cells for isolation and a level for the commercialization of isolated stem cells. Kangstem Biotech has received the support of cord blood stem cell program that is supported by the Seoul City and developed the isolation technology of cord blood-derived stem cells and the mass culturing technology of cord blood-derived stem cells.

Purity

With the original technology of Kangstem Biotech, stem cells with over 95% purity are isolated and cultured, which have the excellent immune control ability, multi-conversion ability and proliferation ability.

Isolation Success Rate

The isolation of stem cells is possible for the cord bloods of more than eight people from the cord bloods obtained from the embryos of ten people with a high rate (80% & higher)

Possible Isolation Time